PC
BIO icon

Polar Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Polar Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$76.4M Sell
148,273
-1,500
-1% -$760K 0.57% 50
2020
Q2 		$67.6M Sell
149,773
-49,661
-25% -$21.9M 0.58% 50
2020
Q1 		$69.9M Buy
199,434
+32,024
+19% +$11.8M 0.75% 33
2019
Q4 		$61.9M Sell
167,410
-44,466
-21% -$15.7M 0.54% 48
2019
Q3 		$70.5M Sell
211,876
-30,579
-13% -$9.98M 0.63% 39
2019
Q2 		$75.8M Sell
242,455
-7,184
-3% -$2.15M 0.67% 42
2019
Q1 		$76.3M Sell
249,639
-1,150
-0.5% -$310K 0.71% 35
2018
Q4 		$58.2M Buy
250,789
+52,000
+26% +$14M 0.62% 48
2018
Q3 		$62.2M Sell
198,789
-26,961
-12% -$8.37M 0.53% 59
2018
Q2 		$65.1K Sell
225,750
-12,250
-5% -$3.38M 0.39% 51
2018
Q1 		$59.5M Buy
238,000
+5,000
+2% +$1.27M 0.6% 46
2017
Q4 		$55.6M Buy
233,000
+97,805
+72% +$23.7M 0.57% 43
2017
Q3 		$30M Buy
+135,195
New +$30.4M 0.34% 98

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Polar Capital's BIO Position: Q3 2020 in Review

Polar Capital reduced its Bio-Rad Laboratories Class A (BIO) stake by 1% in Q3 2020, selling an estimated $760K and leaving 148,273 shares worth $76.4M. The position accounts for 0.57% of the portfolio, ranked #50.

Polar Capital first reported a position in BIO in Q3 2017 and has held it in 13 quarters since. 478 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Polar Capital held 148,273 shares of Bio-Rad Laboratories Class A worth $76.4M as of Q3 2020.
  • Polar Capital sold 1,500 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $760K.
  • Bio-Rad Laboratories Class A made up 0.57% of Polar Capital's portfolio in Q3 2020, its #50 holding.
  • Polar Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2017 and has held it in 13 quarters since.
  • 478 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.